...
...
Next Story

Oxford’s coronavirus vaccine AstraZeneca trial resumes after UK green light

“Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so,” the company said in a statement.

Updated on: Sep 12, 2020, 19:46:24 IST
Advertisement

Pharma giant AstraZeneca on Saturday said it had resumed a Covid-19 vaccine trial after getting the all-clear from British regulators, following a pause caused by a UK volunteer falling ill.

A test tube labelled with the Vaccine is seen in front of AstraZeneca logo. (REUTERS)
A test tube labelled with the Vaccine is seen in front of AstraZeneca logo. (REUTERS)

“Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so,” the company said in a statement.

ALSO WATCH | Delhi airport first in India to get Covid test lab; how it’ll work: Explained

AstraZeneca announced on Wednesday it had “voluntarily paused” its trial of the vaccine developed alongside Oxford University after the volunteer developed an unexplained illness.

An independent committee was drafted in to review safety, in what the company and the World Health Organization described as a routine step.

The committee “has concluded its investigations and recommended to the MHRA that trials in the UK are safe to resume”, AstraZeneca said.

AstraZeneca’s vaccine candidate is one of nine around the world currently in late-stage Phase 3 human trials.

In the United States, the company began enrolling 30,000 volunteers across dozens of sites on August 31, and the inoculation is being tested on smaller groups in Brazil and elsewhere in South America.

The AZD1222 vaccine uses a weakened version of a common cold-causing adenovirus engineered to code for the spike protein that the Covid-19 coronavirus uses to invade cells.

“AstraZeneca is committed to the safety of trial participants and the highest standards of conduct in clinical trials,” Saturday’s statement read.

“The company will continue to work with health authorities across the world and be guided as to when other clinical trials can resume to provide the vaccine broadly, equitably and at no profit during this pandemic.”

 
ABOUT THE AUTHOR
HT News Desk

Follow the latest breaking news, major developments and agenda-setting stories from India and around the world with the newsdesk at Hindustan Times. Operating round the clock, the desk brings together experienced editors, reporters and correspondents to deliver fast, accurate and contextual reporting across subjects that influence public policy, governance, business, society and international affairs. The HT News Desk covers politics, elections, government policies, the economy, business and markets, science and technology, the environment, law and order, infrastructure, education, climate issues and geopolitics, while closely tracking developments across states, institutions and global capitals. The team also leads coverage of major breaking news events, policy announcements, court proceedings, natural disasters, public emergencies and significant international developments. Reports published by the newsdesk are based on information gathered from reporters on the ground, official statements, government agencies, court records, regulatory filings, recognised institutions and other authoritative sources. Stories undergo editorial scrutiny and verification processes to ensure accuracy, fairness and relevance, and are updated as events evolve and additional information becomes available. Whether covering a key political decision in New Delhi, an economic policy shift affecting millions, a landmark court ruling or a major global event, the HT News Desk aims to provide readers with reliable, fact-based journalism that delivers not only the latest developments but also the context and analysis needed to understand their wider implications.

Get the latest World News, breaking headlines, and real-time coverage from key global hotspots, including the US News, Russia, Ukraine, Iran News, and the UAE News. Track developing conflicts, high-stakes diplomacy, and major international events on Hindustan Times.
Get the latest World News, breaking headlines, and real-time coverage from key global hotspots, including the US News, Russia, Ukraine, Iran News, and the UAE News. Track developing conflicts, high-stakes diplomacy, and major international events on Hindustan Times.
SHARE THIS ARTICLE ON
Notifications

Get breaking alerts directly from the newsroom

Notifications are on!You'll be notified when news breaks